| pubmed-article:11287786 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0001779 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0384853 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0392335 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:11287786 | lifeskim:mentions | umls-concept:C0332162 | lld:lifeskim |
| pubmed-article:11287786 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11287786 | pubmed:dateCreated | 2001-4-5 | lld:pubmed |
| pubmed-article:11287786 | pubmed:abstractText | The relative abundance of serotonin 6 receptor (5HT6) in some limbic regions and the high affinity of some antipsychotics for 5HT6 suggest that the 5HT6 gene might play a role in the pathogenesis of schizophrenic disorders. A recent study reported an association between a C267T polymorphism of the 5HT6 gene and schizophrenia. In order to test whether the 5HT6 gene plays a role in the pathogenesis of schizophrenic disorders, patients (n = 148) and control subjects (n = 160) were genotyped for 5HT6. We also investigated the relationship between genotypes and patients' age at onset and cognitive function in schizophrenic patients. Cognitive function in the patients was evaluated by the Mini-Mental State Examination (MMSE). The results demonstrated no significant differences in genotype or allele frequencies between controls and patients. In the patient group, age at onset and MMSE score did not differ significantly among the three 5HT6 genotpyes. The results of this study suggest that the 5HT6 C267T polymorphism plays no major role in susceptibility to the development of schizophrenia and is not related to cognitive impairment or age at onset in schizophrenic patients. Further studies of the relation between 5HT6 polymorphism and the symptoms and the therapeutic response in schizophrenic patients may help to elucidate the role of 5HT6 in the pathogenesis of schizophrenia. | lld:pubmed |
| pubmed-article:11287786 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11287786 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11287786 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11287786 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11287786 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11287786 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11287786 | pubmed:issn | 0302-282X | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:LeeHH | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:WangY CYC | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:LangS LSL | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:LiuW CWC | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:ChaoC HCH | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:ChiuH JHJ | lld:pubmed |
| pubmed-article:11287786 | pubmed:author | pubmed-author:TsaiK YKY | lld:pubmed |
| pubmed-article:11287786 | pubmed:copyrightInfo | Copyright 2001 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:11287786 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11287786 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:11287786 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11287786 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11287786 | pubmed:pagination | 113-6 | lld:pubmed |
| pubmed-article:11287786 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:meshHeading | pubmed-meshheading:11287786... | lld:pubmed |
| pubmed-article:11287786 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11287786 | pubmed:articleTitle | Serotonin 6 receptor polymorphism in schizophrenia: frequency, age at onset and cognitive function. | lld:pubmed |
| pubmed-article:11287786 | pubmed:affiliation | Section of Psychiatry, Yu-Li Veterans Hospital, Hualien, Taiwan, ROC. | lld:pubmed |
| pubmed-article:11287786 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3362 | entrezgene:pubmed | pubmed-article:11287786 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11287786 | lld:entrezgene |
